Invesco Ltd. Vaxcyte, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 1,312,096 shares of PCVX stock, worth $113 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,312,096

Previous 1,078,720 21.63%

Holding current value

$113 Million

Previous $81.5 Million 83.91%

% of portfolio

0.03%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$70.52 - $117.12 $16.5 Million - $27.3 Million	233,376 Added 21.63%	1,312,096 $150 Million
Q2 2024 Aug 13, 2024	SELL	$60.06 - $78.77 $9.36 Million - $12.3 Million	-155,789 Reduced 12.62%	1,078,720 $81.5 Million
Q1 2024 May 14, 2024	BUY	$59.79 - $81.05 $60.2 Million - $81.7 Million	1,007,558 Added 443.95%	1,234,509 $84.3 Million
Q4 2023 Feb 12, 2024	BUY	$45.35 - $63.41 $3.42 Million - $4.78 Million	75,386 Added 49.74%	226,951 $14.3 Million
Q3 2023 Nov 13, 2023	SELL	$46.0 - $53.1 $3.98 Million - $4.6 Million	-86,574 Reduced 36.35%	151,565 $7.73 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $6.89 Million - $10.7 Million	198,671 Added 503.37%	238,139 $11.9 Million
Q1 2023 May 12, 2023	SELL	$36.27 - $47.2 $6.56 Million - $8.53 Million	-180,771 Reduced 82.08%	39,468 $1.48 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $3.79 Million - $8.83 Million	184,189 Added 510.93%	220,239 $10.6 Million
Q3 2022 Nov 14, 2022	SELL	$21.69 - $28.53 $33,532 - $44,107	-1,546 Reduced 4.11%	36,050 $864,000
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $183,995 - $276,618	10,407 Added 38.28%	37,596 $818,000
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $222,073 - $335,272	12,719 Added 87.9%	27,189 $656,000
Q4 2021 Feb 14, 2022	SELL	$19.32 - $26.45 $42,272 - $57,872	-2,188 Reduced 13.13%	14,470 $344,000
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $42,444 - $56,502	2,095 Added 14.39%	16,658 $423,000
Q2 2021 Aug 17, 2021	BUY	$16.45 - $24.06 $239,561 - $350,385	14,563 New	14,563 $328,000

Others Institutions Holding PCVX

# of Institutions

352

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.1B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account